![Edward McDonald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward McDonald
Director/Board Member at Arog Pharmaceuticals, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Vinay K. Jain | M | 64 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | 14 years |
M. Scott Salka | M | 62 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | 6 years |
Jorge Bermudez | M | 72 |
Texas A&M University
| 19 years |
Dean Ferrigno | M | 60 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | 6 years |
George W. Voneiff | M | 62 |
Texas A&M University
| 17 years |
Sumant Ramachandra | M | 55 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Jacob Chacko | M | 45 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Amit Jain | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
John Eckardt | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Nora Ku | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Greg Fisher | M | 39 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Merrick Reese | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Mark Levis | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Alexander Perl | M | - |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Reese | M | - |
Texas A&M University
| 5 years |
Klayton Kovac | M | - |
Texas A&M University
| 5 years |
Michael Weiser | M | - |
Texas A&M University
| 5 years |
Travis W. Hancock | M | - |
Texas A&M University
| 3 years |
Arjun Mohan | M | - |
Texas A&M University
| 5 years |
Joseph L. Dickinson | M | - |
Texas A&M University
| 8 years |
Oliver Huang | M | - |
Texas A&M University
| 5 years |
Nick Losada | M | - |
Texas A&M University
| 6 years |
Zade Satter | M | - |
Texas A&M University
| 7 years |
A. Jordan Latimer | M | - |
Texas A&M University
| 5 years |
Robert Sea | M | - |
Texas A&M University
| 6 years |
Alan Mire | M | - |
Texas A&M University
| 6 years |
Ben Burns | M | - |
Texas A&M University
| 4 years |
Stamets Jill | F | - |
Texas A&M University
| 5 years |
Salpeter Nathaniel | M | - |
Texas A&M University
| 5 years |
Guy Baber | M | - |
Texas A&M University
| 5 years |
Jennifer Oliveri | F | - |
Texas A&M University
| 5 years |
James Sullivan | M | - |
Texas A&M University
| 5 years |
Mark Colby | M | 39 |
Texas A&M University
| 5 years |
Juan Garzon | M | - |
Texas A&M University
| 5 years |
Daniel Alfred Henscheid | M | - |
Texas A&M University
| 5 years |
Thomas D. Saban | M | 72 |
Texas A&M University
| 1 years |
benjamin huskinson | M | - |
Texas A&M University
| 5 years |
William Simmons | M | - |
Texas A&M University
| 6 years |
W. Elsener | M | 39 |
Texas A&M University
| 4 years |
Brent Bunger | M | 41 |
Texas A&M University
| 1 years |
Ulan Erikovich Shardarbekov | M | 39 |
Texas A&M University
| 4 years |
Ronald MacWillie | M | - |
Texas A&M University
| 4 years |
Kyle Rynd | M | - |
Texas A&M University
| 4 years |
Colby McKenzie | M | - |
Texas A&M University
| 4 years |
Debkumar De | M | - |
Texas A&M University
| 5 years |
Kevin M Sirchia | M | - |
Texas A&M University
| 4 years |
Tyler Brous | M | 41 |
Arog Pharmaceuticals, Inc.
![]() Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | 2 years |
ALEX FORSHEY | M | - |
Texas A&M University
| 4 years |
Jesus Antonio Bejarano Rojas | M | 45 |
Texas A&M University
| 3 years |
Logan Barnes | M | - |
Texas A&M University
| 5 years |
Michael Symington | M | - |
Texas A&M University
| 4 years |
Frank Belveal | M | - |
Texas A&M University
| 5 years |
Brian Pownall | M | - |
Texas A&M University
| 4 years |
Jesse Jones | M | - |
Texas A&M University
| 2 years |
Casey Wu | M | - |
Texas A&M University
| 5 years |
Blake Kendrick | M | - |
Texas A&M University
| 1 years |
Andrew T Smith | M | - |
Texas A&M University
| 5 years |
DJ Monteilh | M | - |
Texas A&M University
| 5 years |
Rob Minor | M | - |
Texas A&M University
| 4 years |
Youman Daniel | M | - |
Texas A&M University
| 4 years |
Brad Knotts | M | - |
Texas A&M University
| 4 years |
Robert Gifford | M | 66 |
Texas A&M University
| 2 years |
Robert Eric Fletes | M | - |
Texas A&M University
| 4 years |
Konganapuram V. Nachiappan | M | 68 |
Texas A&M University
| 4 years |
Xuan Yong | M | - |
Texas A&M University
| 4 years |
George Nicholas Giannukos | M | - |
Texas A&M University
| 5 years |
Blake A. Roberts | M | - |
Texas A&M University
| 4 years |
Kelci Johnston | F | - |
Texas A&M University
| 4 years |
Seth Peck | M | - |
Texas A&M University
| 4 years |
Grant Isaminger | M | - |
Texas A&M University
| 4 years |
Brent Norwood | M | - |
Texas A&M University
| 5 years |
Venkatagiri Mirunalini | F | 39 |
Texas A&M University
| 1 years |
Alex Chmelev | M | - |
Texas A&M University
| 3 years |
Eric Doyal | M | - |
Texas A&M University
| 4 years |
Daniel Cotton Senneff | M | - |
Texas A&M University
| 4 years |
Joseph K. Orenek | M | - |
Texas A&M University
| 2 years |
Micah Nance | M | - |
Texas A&M University
| 4 years |
Kevin Smith | M | - |
Texas A&M University
| 2 years |
Robert McTeer | M | 81 |
Texas A&M University
| 3 years |
Aaron M. Jaska | M | - |
Texas A&M University
| 4 years |
Ashley Simpson | F | - |
Texas A&M University
| 4 years |
Shanil Wazirali | M | - |
Texas A&M University
| 5 years |
Chad Knips | M | - |
Texas A&M University
| 4 years |
Kyle Stelma | M | - |
Texas A&M University
| 5 years |
K. Sue Redman | F | 66 |
Texas A&M University
| 4 years |
Matthew Tramonte | M | - |
Texas A&M University
| 4 years |
Andrew McMillan | M | - |
Texas A&M University
| 4 years |
Chris Knight | M | - |
Texas A&M University
| 4 years |
A. Parker | M | 37 |
Texas A&M University
| 1 years |
Doss Cunningham | M | - |
Texas A&M University
| 5 years |
Vivek Siwatch | M | - |
Texas A&M University
| 1 years |
Matthew Tarver | M | - |
Texas A&M University
| 4 years |
Ryan Hazlett | M | - |
Texas A&M University
| 4 years |
George B. Montague | M | - |
Texas A&M University
| 4 years |
Kerr Friedman | M | - |
Texas A&M University
| 5 years |
Marc Posso | M | - |
Texas A&M University
| 1 years |
Chace Hobbs | M | - |
Texas A&M University
| 4 years |
Chris King | M | - |
Texas A&M University
| 4 years |
Travis Zeh Bartlett | M | - |
Texas A&M University
| 4 years |
Carson Pfluger | M | - |
Texas A&M University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Edward McDonald
- Personal Network